Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Luis Mora Vieira

Clinical Cardiac Electrophysiology Delray Beach, FL Medical Doctor

NPI 1104003664 CMS profile 935529

5258 Linton Blvd Ste 106, Ste 106, Delray Beach, FL 33484

Open in the dashboard

General payments

$52,106

686 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Luis Mora Vieira of Delray Beach, FL is reported in the CMS Open Payments database as having received $52,106 across 686 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 77th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,732 90
2024 General $6,252 137
2023 General $17,213 134
2022 General $5,477 111
2021 General $3,189 95
2020 General $2,532 55
2019 General $8,711 64

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Luis Mora Vieira
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Luis Mora Vieira were reported at $8,732. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Luis Mora Vieira Clinical Cardiac Electrophysiology median Middle half National median
2019 $8,711 $2,361 $585–$8,260 $163
2020 $2,532 $993 $247–$4,351 $114
2021 $3,189 $1,185 $326–$4,739 $132
2022 $5,477 $2,073 $554–$6,789 $149
2023 $17,213 $2,568 $759–$8,159 $160
2024 $6,252 $2,557 $703–$7,403 $164
2025 $8,732 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $29,405 408 payments
  2. Boston Scientific Corporation $17,493 64 payments
  3. Biosense Webster, Inc. $588 14 payments
  4. Medtronic Vascular, Inc. $534 6 payments
  5. Janssen Pharmaceuticals, Inc $532 25 payments
  6. Medtronic, Inc. $463 23 payments
  7. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $430 26 payments
  8. Biotronik Inc. $398 7 payments
  9. Cardiva Medical, Inc. $354 19 payments
  10. Sanofi-Aventis U.S. LLC $318 15 payments
  11. Other $1,590 79 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $20,822 651 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $16,500 14 payments
  3. Consulting Fee $13,164 12 payments
  4. Travel and Lodging $1,612 8 payments
  5. Education $8 1 payment
Products named General payments · program years 2019–2025
  1. ENSITE Electrophysiology $7,356 40 payments
  2. Ensite Cardiac Mapping System $6,080 12 payments
  3. General - EP $3,778 4 payments
  4. ACCENT $1,575 2 payments
  5. AVEIR Structural Heart $1,114 31 payments
  6. EnSite Precision Cardiac Mapping System Electrophysiology $1,096 15 payments
  7. AVEIR Cardiac Rhythm Management $962 32 payments
  8. AVEIR Cardiac Rhythm Management $961 50 payments
  9. EnSite Precision Cardiac Mapping System Electrophysiology $922 4 payments
  10. ENSITE Structural Heart $843 18 payments
  11. Other $13,463 420 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 24 drugs

Part D claims

1,368

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$559,898

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

38.7%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Xarelto Rivaroxaban Brand 223 $248,929
Eliquis Apixaban Brand 139 $178,956
Multaq Dronedarone Hcl Brand 83 $100,319
Entresto Sacubitril/Valsartan Brand 15 $17,753
Metoprolol Succinate Generic 248 $3,370
Diltiazem 12hr Er Diltiazem Hcl Brand 14 $2,852
Amiodarone Hcl Generic 99 $1,629
Sotalol Sotalol Hcl Brand 36 $1,122
Flecainide Acetate Generic 40 $877
Midodrine Hcl Generic 16 $695

The 10 drugs with the highest cost, of 24 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 86 billing codes

Paid by Medicare

$483,518

Medicare's payments for the services billed

Medicare patients

1,024

Average age 81

Services billed

4,723

493 women, 531 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 70%
Ischemic heart disease 64%
Arthritis 61%
Chronic kidney disease 48%
Heart failure 47%
Diabetes 37%
Depression 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XARELTO
  • Janssen Pharmaceuticals, Inc $185
$185 223 —
MULTAQ
  • SANOFI-AVENTIS U.S. LLC $56
$56 83 —
ELIQUIS
  • E.R. Squibb & Sons, L.L.C. $16
$16 139 —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

686 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record